Table 1. Clinical and demographic characteristics and chest CT findings of the study patients.

A: azithromycin; F: female; Fa: favipiravir; M: male; CABG: coronary artery bypass graft; CAD: coronary artery disease; COVID-19: coronavirus disease 2019; DM: diabetes mellitus; GGO: ground-glass opacities; H: hydroxychloroquine; HT: hypertension; LVH: left ventricular hypertrophy; MP: methylprednisolone; RLL: right lower lobe; RML: right middle lobe; T: tocilizumab.

Patient	Sex, age	Comorbid conditions	Length of hospital stay (days)	Length of ICU stay (days)	Length of mechanical ventilation (days)	Time between the last chest CT scan and death (days)	Chest CT findings	COVID-19 treatment
Patient 1	M, 62	CABG, CAD, LVH, HT	9	0	0	-	-	A + H
Patient 2	M, 39	DM, HT, LVH	22	4	0	3	GGO prominent in RLL, cardiomegaly	A + H + Fa + MP
Patient 3	F, 66	CAD, LVH, HT	19	7	7	5	Bilateral extensive GGO, consolidation in basal areas, cardiomegaly, pericardial effusion	A + H + Fa + T + MP + plasma
Patient 4	F, 59	CAD, LVH, HT, DM	23	14	19	3	GGO, consolidation, subsegmental atelectasis and 4 cm pleural effusion, cardiomegaly, pericardial effusion	A + H + Fa + T + MP + plasma
Patient 5	M, 93	CAD, LVH, HT, DM	1	21	17	5	GGO in RLL, consolidation in the left lung, left diaphragm elevation, cardiomegaly, pleural effusion	A + H + Fa + T + MP + plasma
Patient 6	M, 55	DM, LVH	20	5	3	4	Bibasilar and RML GGO, cardiomegaly, pericardial effusion	A + H + Fa + MP
Patient 7	M, 75	CAD, DM	19	6	5	3	Bibasilar GGO more prominent on right side, pleural and pericardial effusion, cardiomegaly	A + H + Fa + MP